Back60 Degrees Pharmaceuticals- Warrants (16/05/2028) Overview

60 Degrees Pharmaceuticals- Warrants (16/05/2028) Other Current Liabilities

Latest other current liabilities for SXTPW: $1.9M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$1.88M
4.06% YoYΔ $73194.00 vs prior year quarter

Peer trimmed avg / median

Loading

60 Degrees Pharmaceuticals- Warrants (16/05/2028) Other Current Liabilities History

Loading

60 Degrees Pharmaceuticals- Warrants (16/05/2028) vs. peers: Other Current Liabilities Comparison

Loading

60 Degrees Pharmaceuticals- Warrants (16/05/2028) Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

60 Degrees Pharmaceuticals- Warrants (16/05/2028) (SXTPW) FAQ

The latest other current liabilities for SXTPW is $1.9M as of March 2026. That compares with $1.8M in the prior-year period — up 4.1% year over year. Investors often review this figure alongside 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SXTPW's other current liabilities moved from $1.8M to $1.9M — a 4.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s operating scale or balance-sheet position.

A other current liabilities figure of $1.9M for SXTPW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SXTPW's other current liabilities ($1.9M), review year-over-year change from $1.8M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.